SA Tuberculosis Vaccine Initiative

Search

March 2018

19 March 2018 Launch of TB under Spotlight Science Engagement - 19 Mar 2018 - 08:15

February 2018

19 February 2018 Results from innovative tuberculosis vaccine trial show potential for new BCG revaccination strategies and hope for subunit vaccines - 19 Feb 2018 - 20:00

November 2017

Vacancy Research Pharmacist - 21 Nov 2017 - 12:15
New Gobal commitment to end TB - 20 Nov 2017 - 08:30
Progression from infection to Pulmonary Tuberculosis follows distinct timeline - 17 Nov 2017 - 08:15
4 November 2017 SATVI offers bursary to cover Registration fee to cover SciMathUS program - 14 Nov 2017 - 09:00
9 November 2017 Research Published: TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development - 9 Nov 2017 - 14:15
25 October 2017 Research Published Polyfunctional CD4+TCells as targets for vaccination - 6 Nov 2017 - 14:45

October 2017

5 October 2017 RESEARCH: Safety and Immunogenicity Immunogenicity of newborn MVA 85 A vaccination and selective delayed Bacille Calmette-Guerin for infants of HIV infected mothers: a Phase 2 Randomized Controlled Trial - 5 Oct 2017 - 11:30
3 October 2017 Research: Host blood signatures RNA predict the outcome of tuberculosis treatment - 3 Oct 2017 - 10:30

September 2017

21 September 2017 Vacancy Research Officer: Systems Immunology - 21 Sep 2017 - 18:15
14 September 2017 Research: Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population - 15 Sep 2017 - 09:00
8 September 2017 Research: A Functional Toll-Interacting Protein Variant associated with Bacillus Calmette-Guerin Specific Immune Response and Tuberculosis - 8 Sep 2017 - 08:00
7 September 2017 Research Published: Identifying specificity groups in T cell receptor repertoire - 7 Sep 2017 - 17:15
6 september 2017 Research Protein kinase C-delta (PKCd), a marker of inflammation and tuberculosis disease progression in humans, is important for optimal macrophage killing effector functions and survival in mice - 6 Sep 2017 - 20:15
6 September 2017 Research Published: Protein kinase C-delta (PKCd), a marker of inflammation and tuberculosis disease progression in humans, is important for optimal macrophage killing effector functions and survival in mice - 6 Sep 2017 - 20:15
6 September 2017 SATVI marks 3000th patient screened in CORTIS HR study. - 6 Sep 2017 - 19:00
2 September 2017 Beadmaking to Beat TB - 6 Sep 2017 - 10:15

August 2017

23 August 2017 Research Published: The CSF Immune Response in HIV-1–Associated Cryptococcal Meningitis: Macrophage Activation, Correlates of Disease Severity, and Effect of Antiretroviral Therapy - 23 Aug 2017 - 14:30
15 August 2017 NEW VACANCY: Laboratory Technologist - 15 Aug 2017 - 14:30
14 August 2017 Research: Optimization and interpretation of serial QuantiFERON testing to measure acquisition of M. tuberculosis infection - 15 Aug 2017 - 13:15
9 August 2017 SATVI hosts delegation from the Cape Winelands Education Department - 15 Aug 2017 - 11:45
7 August 2017 Research: Differential Recognition of Mtb-specific Epitopes as a Function of Tuberculosis Disease History - 14 Aug 2017 - 22:15
30 July 2017 Welcome to Professor David Lewinsohn - 5 Aug 2017 - 13:45

July 2017

17 July 2017 Research Published: Cross-species Mycobacterial Inhibition Assay Project 2010 -2014 - 17 Jul 2017 - 09:45
6 July 2017 Latest Research Impact of isoniazid preventive therapy on the evaluation of long-term effectiveness of infant MVA85A vaccination - 6 Jul 2017 - 12:30
6 July 2017 Research Published: Impact of Isoniazid preventive therapy on the evaluation of long-term effectiveness of infant MVA85A vaccination - 6 Jul 2017 - 12:30

June 2017

1 July 2016 SATVI marks Mandela Day - 29 Jun 2017 - 08:00
29 June 2017 SATVI says farewell to Dr Hennie Geldenhuys - 28 Jun 2017 - 22:30
26 June 2017 Research: Identifying specificity groups in the T cell receptor repertoire - 26 Jun 2017 - 13:30
Determining M. tuberculosis components to be included in vaccines - 21 Jun 2017 - 07:30
5 June 2017 Research Long-lasting Tuberculous Pleurisy - 5 Jun 2017 - 12:30
2 June 2017 SATVI presents Community Engagement Projects at Stellenbosch Conference - 5 Jun 2017 - 11:00
2 June 2017 Beat TB Newsletter - 2 Jun 2017 - 15:15
1 June 2017 SATVI to exhibit at Art of Medicine Exhibit on Monday 5 June 2017 - 1 Jun 2017 - 20:00

May 2017

27 May 2017 Research Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial. - 27 May 2017 - 13:45
24 May 2017 Research Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study - 24 May 2017 - 21:45
15 May 2017 Local TB drama makes it to national TV - 20 May 2017 - 12:30
12 May 2017 International Nurses Day - 12 May 2017 - 14:30
5 May 2017 Research Published A Functional TOLLIP Variant is Associated with BCG-Specific Immune Responses and Tuberculosis. - 5 May 2017 - 21:15

Pages

Contact us

General Enquiries:

Tel +27 21 406 6791

Worcester Field Site Office

Tel+ 27 23 346 5400

Email: Information

Cape Town Offices:

Wernher and Beit South Building, Room S2.01, University of Cape Town , Anzio Road, OBSERVATORY, 7925

Tel: +27 21 406 6791

Fax:+27 21 406 6081

Email: Director

Worcester Site Office:

SATVI Project Office, University of Cape Town, Brewelskloof Hospital,  Haarlem Street, WORCESTER, 6850.

Tel: +27 23 346 5400

Fax: +27 23 346  5406

Email: Field Site Manager

Google maps:  Click here GPS: 33.620455, 19.458576

Map to Worcester Field Office